Factory Capital kicks off $25m bid to make women’s midlife health an ‘investable category’
The Sydney firm will open a US-based research institute and seek to make five to 10 business investments in the untapped peri- and post-menopause healthcare market.
Sydney-based investment firm Factory Capital is planning to invest upwards of $25 million to build businesses targeting peri- and post-menopause — or “midlife” — interventions.
The outlay will support establishing the Institute Advancing Women’s Health (InAWH), a new non-profit working with clinicians and researchers to coalesce around the $490 billion market opportunity.
“What we’re really doing is creating a market,” Factory Capital partner and managing director Anna Samuelsson told Capital Brief.
“We’re helping women achieve improved midlife health by building an investable category. It’s currently too fragmented, which makes it really difficult for institutional capital to deploy efficiently into the sector.”
